<p>Limoneira（納斯達克代碼：LMNR - 獲取免費報告）於週二發佈了其財報。該公司報告本季度每股收益（EPS）為（$0.49），低於市場共識預期的（$0.12），差距為（$0.37），據 Zacks 報道。Limoneira 的股本回報率為負 5.01%，淨利潤率為負 5.69%。</p>
<h2>Limoneira 股價下跌 3.8%</h2>
<p>週二，LMNR 股票交易下跌$0.54，報$13.86。該股票成交 186,950 股，而其平均成交量為 70,153 股。該公司的 50 日移動平均價格為$14.14，200 日移動平均價格為$14.97。公司的債務與股本比率為 0.35，流動比率為 1.80，速動比率為 1.66。該公司的市值為 2.5017 億美元，市盈率為-25.20，貝塔值為 0.41。Limoneira 的 52 周低點為$12.69，52 周高點為$25.57。</p>
<h2>Limoneira 宣佈分紅</h2>
<p>該公司最近還宣佈了一項季度分紅，將於 1 月 16 日（星期五）支付。12 月 30 日（星期二）登記的投資者將獲得$0.075 的分紅。這代表着每年$0.30 的分紅和 2.2% 的分紅收益率。該分紅的除息日為 12 月 30 日（星期二）。Limoneira 的分紅支付比率（DPR）目前為-54.55%。</p>
<h2>分析師設定新目標價</h2>
<p>幾位股票研究分析師對 LMNR 股票發表了看法。Weiss Ratings 在週一的研究報告中重申了對 Limoneira 股票的 “賣出（d）” 評級。Stephens 在 9 月 12 日（星期五）的研究報告中開始覆蓋 Limoneira，給予 “持平” 評級和$18.00 的目標價。Roth Capital 在 9 月 15 日（星期一）的報告中重申了對 Limoneira 股票的 “買入” 評級。最後，Zacks Research 在 11 月 11 日（星期二）的研究報告中將 Limoneira 的評級從 “強烈賣出” 上調至 “持有”。兩位分析師給予該股票 “買入” 評級，兩位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “持有”，共識目標價為$20.50。</p>
<p><strong>獲取我們關於 Limoneira 的最新研究報告</strong></p>
<h2>Limoneira 的機構交易</h2>
<p>對沖基金最近對該公司的持倉進行了調整。Jacobs Levy Equity Management Inc.在第一季度購買了 Limoneira 的新股份，價值約$256,000。Jane Street Group LLC 在第一季度收購了 Limoneira 的新股份，價值約$335,000。Geode Capital Management LLC 在第二季度將其在 Limoneira 的持倉提高了 5.6%。Geode Capital Management LLC 現在擁有 397,720 股該公司的股票，價值$6,226,000，在上個季度又購買了 20,913 股。摩根大通在第二季度將其在 Limoneira 的持倉提高了 248.7%。摩根大通現在擁有 44,238 股該公司的股票，價值$692,000，在上個季度又購買了 31,552 股。最後，Rhumbline Advisers 在第二季度將其在 Limoneira 的持倉提高了 29.5%。Rhumbline Advisers 現在擁有 24,943 股該公司的股票，價值$390,000，在上個季度又購買了 5,682 股。機構投資者和對沖基金持有該公司 64.35% 的股份。</p>
<h2>關於 Limoneira</h2>
<p>（獲取免費報告）</p>
<p>Limoneira 公司，納斯達克代碼：LMNR，成立於 1893 年，總部位於加利福尼亞州聖保拉，是一家多元化的農業企業和房地產公司。作為美國最古老的柑橘生產商之一，Limoneira 在種植和營銷高質量柑橘類水果、鱷梨和特種作物方面建立了良好的聲譽。該公司的垂直整合模式涵蓋了農業、包裝、加工和營銷活動，旨在將新鮮農產品提供給國內和國際市場。</p>
<p>在其農業業務中，Limoneira 專注於檸檬、橙子和鱷梨，採用現代灌溉、採摘和包裝技術，以保持產品質量和供應的穩定。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票超過 Limoneira</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者警報：微型 “$3 AI 奇蹟股票” 即將爆發</li>
<li>是否可以從資本利得税中扣除任何費用？</li>
<li>巴菲特、蓋茨和貝索斯悄悄拋售股票——原因在這裏</li>
<li>忘掉 AI，這將是下一個重大科技突破</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TE1OUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TE1OUg"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 Limoneira 嗎？</h2>
<p>在考慮 Limoneira 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已經識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Limoneira 並不在名單上。</p>
<p>雖然 Limoneira 目前在分析師中獲得 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

LMNR

<p>Limoneira（納斯達克代碼：LMNR）報告的季度每股收益為（$0.49），低於市場普遍預期的（$0.12）。該公司的淨利潤率為負 5.69%，股本回報率為負 5.01%。股價下跌 3.8%，至$13.86。Limoneira 宣佈季度股息為$0.075，收益率為 2.2%。分析師對該股票的評級不一，市場共識目標價為$20.50。機構投資者持有該股票的 64.35%</p>

<p>Limoneira (NASDAQ:LMNR - Get Free Report) released its earnings results on Tuesday. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.37), Zacks reports. Limoneira had a negative return on equity of 5.01% and a negative net margin of 5.69%.</p>
<div class="lb-trans"><p>Limoneira（納斯達克代碼：LMNR - 獲取免費報告）於週二發佈了其財報。該公司報告本季度每股收益（EPS）為（$0.49），低於市場共識預期的（$0.12），差距為（$0.37），據 Zacks 報道。Limoneira 的股本回報率為負 5.01%，淨利潤率為負 5.69%。</p>
</div><h2>Limoneira Trading Down 3.8%</h2>
<div class="lb-trans"><h2>Limoneira 股價下跌 3.8%</h2>
</div><p>Shares of LMNR stock traded down $0.54 during trading on Tuesday, hitting $13.86. 186,950 shares of the stock traded hands, compared to its average volume of 70,153. The firm's fifty day moving average price is $14.14 and its 200-day moving average price is $14.97. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.80 and a quick ratio of 1.66. The firm has a market capitalization of $250.17 million, a P/E ratio of -25.20 and a beta of 0.41. Limoneira has a 52-week low of $12.69 and a 52-week high of $25.57.</p>
<div class="lb-trans"><p>週二，LMNR 股票交易下跌$0.54，報$13.86。該股票成交 186,950 股，而其平均成交量為 70,153 股。該公司的 50 日移動平均價格為$14.14，200 日移動平均價格為$14.97。公司的債務與股本比率為 0.35，流動比率為 1.80，速動比率為 1.66。該公司的市值為 2.5017 億美元，市盈率為-25.20，貝塔值為 0.41。Limoneira 的 52 周低點為$12.69，52 周高點為$25.57。</p>
</div><h2>Limoneira Announces Dividend</h2>
<div class="lb-trans"><h2>Limoneira 宣佈分紅</h2>
</div><p>The business also recently declared a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Tuesday, December 30th will be issued a $0.075 dividend. This represents a $0.30 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, December 30th. Limoneira's dividend payout ratio (DPR) is currently -54.55%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度分紅，將於 1 月 16 日（星期五）支付。12 月 30 日（星期二）登記的投資者將獲得$0.075 的分紅。這代表着每年$0.30 的分紅和 2.2% 的分紅收益率。該分紅的除息日為 12 月 30 日（星期二）。Limoneira 的分紅支付比率（DPR）目前為-54.55%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>Several equities research analysts have weighed in on LMNR shares. Weiss Ratings reaffirmed a &#34;sell (d)&#34; rating on shares of Limoneira in a research report on Monday. Stephens assumed coverage on Limoneira in a research report on Friday, September 12th. They set an &#34;equal weight&#34; rating and a $18.00 target price on the stock. Roth Capital reiterated a &#34;buy&#34; rating on shares of Limoneira in a report on Monday, September 15th. Finally, Zacks Research upgraded Limoneira from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday, November 11th. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of &#34;Hold&#34; and a consensus price target of $20.50.</p>
<div class="lb-trans"><p>幾位股票研究分析師對 LMNR 股票發表了看法。Weiss Ratings 在週一的研究報告中重申了對 Limoneira 股票的 “賣出（d）” 評級。Stephens 在 9 月 12 日（星期五）的研究報告中開始覆蓋 Limoneira，給予 “持平” 評級和$18.00 的目標價。Roth Capital 在 9 月 15 日（星期一）的報告中重申了對 Limoneira 股票的 “買入” 評級。最後，Zacks Research 在 11 月 11 日（星期二）的研究報告中將 Limoneira 的評級從 “強烈賣出” 上調至 “持有”。兩位分析師給予該股票 “買入” 評級，兩位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “持有”，共識目標價為$20.50。</p>
</div><p><strong>Get Our Latest Research Report on Limoneira</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 Limoneira 的最新研究報告</strong></p>
</div><h2>Institutional Trading of Limoneira</h2>
<div class="lb-trans"><h2>Limoneira 的機構交易</h2>
</div><p>Hedge funds have recently made changes to their positions in the business. Jacobs Levy Equity Management Inc. purchased a new stake in Limoneira during the first quarter worth approximately $256,000. Jane Street Group LLC acquired a new stake in Limoneira during the first quarter worth approximately $335,000. Geode Capital Management LLC lifted its position in shares of Limoneira by 5.6% during the 2nd quarter. Geode Capital Management LLC now owns 397,720 shares of the company's stock worth $6,226,000 after buying an additional 20,913 shares during the last quarter. JPMorgan Chase &amp; Co. boosted its holdings in shares of Limoneira by 248.7% in the 2nd quarter. JPMorgan Chase &amp; Co. now owns 44,238 shares of the company's stock valued at $692,000 after buying an additional 31,552 shares in the last quarter. Finally, Rhumbline Advisers boosted its holdings in shares of Limoneira by 29.5% in the 2nd quarter. Rhumbline Advisers now owns 24,943 shares of the company's stock valued at $390,000 after buying an additional 5,682 shares in the last quarter. Institutional investors and hedge funds own 64.35% of the company's stock.</p>
<div class="lb-trans"><p>對沖基金最近對該公司的持倉進行了調整。Jacobs Levy Equity Management Inc.在第一季度購買了 Limoneira 的新股份，價值約$256,000。Jane Street Group LLC 在第一季度收購了 Limoneira 的新股份，價值約$335,000。Geode Capital Management LLC 在第二季度將其在 Limoneira 的持倉提高了 5.6%。Geode Capital Management LLC 現在擁有 397,720 股該公司的股票，價值$6,226,000，在上個季度又購買了 20,913 股。摩根大通在第二季度將其在 Limoneira 的持倉提高了 248.7%。摩根大通現在擁有 44,238 股該公司的股票，價值$692,000，在上個季度又購買了 31,552 股。最後，Rhumbline Advisers 在第二季度將其在 Limoneira 的持倉提高了 29.5%。Rhumbline Advisers 現在擁有 24,943 股該公司的股票，價值$390,000，在上個季度又購買了 5,682 股。機構投資者和對沖基金持有該公司 64.35% 的股份。</p>
</div><h2>About Limoneira</h2>
<div class="lb-trans"><h2>關於 Limoneira</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Limoneira Company NASDAQ: LMNR, founded in 1893 and based in Santa Paula, California, is a diversified agribusiness and real estate enterprise. As one of the oldest citrus producers in the United States, Limoneira has built a reputation for cultivating and marketing high-quality citrus fruits, avocados and specialty crops. The company's vertically integrated model encompasses farming, packing, processing and marketing activities designed to deliver fresh produce to domestic and international markets.</p>
<div class="lb-trans"><p>Limoneira 公司，納斯達克代碼：LMNR，成立於 1893 年，總部位於加利福尼亞州聖保拉，是一家多元化的農業企業和房地產公司。作為美國最古老的柑橘生產商之一，Limoneira 在種植和營銷高質量柑橘類水果、鱷梨和特種作物方面建立了良好的聲譽。該公司的垂直整合模式涵蓋了農業、包裝、加工和營銷活動，旨在將新鮮農產品提供給國內和國際市場。</p>
</div><p>In its agricultural operations, Limoneira specializes in lemons, oranges and avocados, employing modern irrigation, harvesting and packing technologies to maintain consistent product quality and supply.</p>
<div class="lb-trans"><p>在其農業業務中，Limoneira 專注於檸檬、橙子和鱷梨，採用現代灌溉、採摘和包裝技術，以保持產品質量和供應的穩定。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Limoneira</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
<li>Forget AI, This Will Be the Next Big Tech Breakthrough</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 Limoneira</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者警報：微型 “$3 AI 奇蹟股票” 即將爆發</li>
<li>是否可以從資本利得税中扣除任何費用？</li>
<li>巴菲特、蓋茨和貝索斯悄悄拋售股票——原因在這裏</li>
<li>忘掉 AI，這將是下一個重大科技突破</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TE1OUg" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=LMNR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Limoneira Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 Limoneira 嗎？</h2>
</div><p>Before you consider Limoneira, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Limoneira 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Limoneira wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已經識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Limoneira 並不在名單上。</p>
</div><p>While Limoneira currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Limoneira 目前在分析師中獲得 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Limoneira（納斯達克股票代碼：LMNR）公佈季度財報結果